Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT04863066 Not yet recruiting - HIV-1 Clinical Trials

Third-Generation CAR-T-cell Therapy in Individuals With HIV-1 Infection

TCTIWHI
Start date: May 1, 2021
Phase: Phase 1
Study type: Interventional

To evaluate the safety of autologous CAR-T-cell therapy in individuals lived with HIV-1 infection, CAR T cells are infused after ex vivo expansion and transduction with lentiviral vectors encoding a broadly neutralizing HIV-1 scFv antibody.

NCT ID: NCT04862403 Completed - Newborn; Infection Clinical Trials

The Effect of Umbilical Cord Clamping Distance

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

A randomized control trial was conducted to test the effect of umbilical cord clamping distance on cord separation time and umbilical cord microbial colonization in neonates.

NCT ID: NCT04859023 Completed - SARS-CoV Infection Clinical Trials

Comparison of Strategies Based on RT-PCR or Antigenic Test for the Screening of SARS-CoV-2 Infection (COVID-19).

AutoCoV
Start date: February 22, 2021
Phase: N/A
Study type: Interventional

The virological diagnosis of SARS-CoV-2 infection is pivotal for the control of the outbreak by large screening of a- or pauci-symptomatic subjects. Despite nasopharyngeal swabbing tested by RT-PCR is considered as the gold standard, new strategies based on self-samples are considered as valuable alternatives because of their non-invasiveness and ability to be performed in the absence healthcare worker, especially when the subject is asymptomatic and needs to be tested repetitively. The aim of the present project is to evaluate two strategies both based on self-samples: (i) a saliva sample combined to an anterior nare self-swabbing tested by antigenic test versus (ii) a saliva sample tested by RT-PCR. The comparison will be performed during a mass screening of the population of the city of Saint-Etienne (170000 inhabitants), France. The sensitivity of the rapid antigenic test will be evaluated in comparison to that of RT-PCR considered as gold standard.

NCT ID: NCT04856878 Not yet recruiting - Clinical trials for Central Line-associated Bloodstream Infection (CLABSI)

Effect of Vancomycin After Catheter Replacement

VanCat
Start date: June 1, 2021
Phase: Phase 4
Study type: Interventional

Randomized controlled trial of the effect of a single-dose intravenous Vancomycin after catheter replacement for suspected central line-associated bloodstream infection on resolution of infection in critically ill patients.

NCT ID: NCT04852718 Recruiting - Covid19 Clinical Trials

Rehabilitation Program for the Sequelae of COVID 19 Infection

ISIS
Start date: April 13, 2021
Phase:
Study type: Observational

SUBPROJECT 1: Describe the situation of post-Covid patients in terms of muscle (skeletal and respiratory), cognitive, emotional and health-related quality of life in the 1st visit of the multidisciplinary post-covid rehabilitation consultation at the Hospital. Retrospective observational study. The data collected in clinical records during the first visit in the post-covid Rehabilitation consultation will be analysed. SUBPROJECT 2: Evaluate the response to a personalized rehabilitation program in patients with post-covid sequelae in terms of muscle (skeletal and respiratory), and health-related quality of life. Prospective observational study of a single cohort of patients. The data will be collected from successive clinical visits.

NCT ID: NCT04849312 Not yet recruiting - Asthma Clinical Trials

Prediction of 30-Day Readmission Using Machine Learning

Start date: March 20, 2022
Phase:
Study type: Observational

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict the likelihood of 30-day readmission throughout a patient's admission. This algorithm was then validated in a validation cohort.

NCT ID: NCT04848610 Completed - COVID-19 Infection Clinical Trials

The Factors That Affect the Infection of COVID-19

Start date: October 18, 2020
Phase:
Study type: Observational

The number of new Coronavirus-2019 (Covid-19) cases is increasing day by day despite the warnings "Stay at home! Wear a mask! Keep social distance!". The aim of this descriptive study is to determine the risk factors that affect the Covid-19 infection in Turkey. The online link of the form created on Google forms was sent to the participants' phones between 18.10.2020 and 18.11.2020.

NCT ID: NCT04848441 Not yet recruiting - Covid19 Clinical Trials

Risk of COVID-19 Infection After Vaccination

Start date: May 1, 2021
Phase:
Study type: Observational

The purpose of this observational nationwide study is to evaluate the effects of three different COVID-19 vaccines for the outcome of different severities of incident COVID infection.

NCT ID: NCT04846010 Recruiting - Depression Clinical Trials

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

sequelae
Start date: March 1, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

Post-acute sequelae of SARS-CoV-2 infection can cause multiple system function disorders, and complicated symptoms last for an extended period. The virus can cause this continued infection, or the virus causes immune system function disorder and post-infectious autoimmune disease. The clinical symptoms can be smell loss, taste loss to liver function disorder, kidney function failure, different. No matter how complicated the systems showed in the clinic, all of the symptoms are due to the specific cells being damaged. Our clinical study is focused on recovering the damaged structure and function of the cells that could restore the organ function back to normal or close to normal

NCT ID: NCT04845984 Completed - Covid19 Clinical Trials

Evaluation of the Prevalence of SARS-CoV-2 Infection in the Healthcare Workers (HCWs) in Four Hospital of the Alpine Region

PACAAP
Start date: September 1, 2020
Phase:
Study type: Observational

The PACAAP study aims to report the seroprevalence of SARS-CoV-2 IgG antibodies among HCWs testing during the massive campaign screening set up in France by French ministry of Health and national authorities in four hospital of the Alpine region.